Fermenta Biotech

Fermenta Biotech Payout Ratio

The Dividend Payout Ratio of Fermenta Biotech (506414.BO) as of Oct 22, 2026 is 9.49 %. In the previous year, Dividend Payout Ratio was -15.65 % — a change of -160.62% (higher).

Payout Ratio

9.49 %

YoY

-160.62%

Last updated:

Dividend Payout Ratio of Fermenta Biotech is 2025 9.49 % . Dividend Payout Ratio of Fermenta Biotech was 2024 -15.65 % . It decreases by -160.62% higher compared to the previous year.

The payout ratio is around 9% of earnings.

The Fermenta Biotech Payout Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Payout Ratio
Date
Payout Ratio
Jan 1, 2018
3.40 INR
Jan 1, 2019
5.12 INR
Jan 1, 2020
16.30 INR
Jan 1, 2021
15.93 INR
Jan 1, 2022
23.47 INR
Jan 1, 2023
-7.00 INR
Jan 1, 2024
-15.65 INR
Jan 1, 2025
9.49 INR
The Fermenta Biotech Payout Ratio history
YEARPayout RatioYoY
9.49 %-160.62%
-15.65 %+123.45%
-7.00 %-129.85%
23.47 %+47.29%
15.93 %-2.22%
16.30 %+218.28%
5.12 %+50.54%
3.40 %-85.02%
22.71 %-111.23%
-202.16 %-161.34%
329.60 %+746.80%
38.92 %+138.84%
16.30 %-73.72%
62.01 %+104.85%
30.27 %-24.20%
39.94 %-49.36%
78.86 %+79.81%
43.86 %+151.83%
17.42 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fermenta Biotech Stock analysis

What does Fermenta Biotech do? Fermenta Biotech Ltd manufactures and supplies Vitamin D3, operating through its Chemicals/Bulk Drug segment that produces bulk drugs and enzymes for pharmaceuticals, dietary supplements, food fortification, animal feed, veterinary, and rodenticide industries. The Property segment generates revenue by renting and selling properties. The company's proprietary enzyme portfolio supports biopharmaceutical product development, while its nutritional ingredients include fish oil-derived cholesterol for aquaculture, natural astaxanthin, and vitamin AD2 premix, all sold to customers in the specified sectors. The Chemicals/Bulk Drug segment serves pharmaceutical, dietary supplement, food and beverage, animal feed, veterinary, and rodenticide markets with bulk drugs and enzymes. The Property segment focuses on real estate transactions, providing rental and sales services for its properties. Fermenta Biotech's product portfolio targets industries requiring specialized biopharmaceutical technologies and nutritional supplements, with key offerings like Vitamin D3, fish oil cholesterol, astaxanthin, and vitamin AD2 premix directly sold to these sectors. Fermenta Biotech Ltd's revenue streams come from the sale of Vitamin D3 and other bulk drugs through its Chemicals/Bulk Drug segment, while the Property segment contributes through property rentals and sales. The company's nutritional ingredients, such as fish oil-derived cholesterol, natural astaxanthin, and vitamin AD2 premix, are sold to industries including pharmaceuticals, dietary supplements, food fortification, animal feed, and veterinary sectors, with no additional brand or customer details provided beyond the business description. Fermenta Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fermenta Biotech stock

Dividend Payout Ratio of Fermenta Biotech is 9.49 % in 2025.

Dividend Payout Ratio of Fermenta Biotech changed from -15.65 % to 9.49 %, representing a -160.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Payout Ratio Fermenta Biotech since 2006 – with annual values, charts, and detailed analysis.

The payout ratio measures the percentage of net income distributed as dividends. A sustainable payout ratio leaves room for reinvestment and growth.

Dividend Payout Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Payout Ratio's Fermenta Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Fermenta Biotech

All Key Metrics — Fermenta Biotech